Mythic Therapeutics Announces Appointment of Gilles Gallant, BPharm PhD FOPQ as Chief Development Officer
Waltham, Mass., August 23 2022 (BUSINESS WIRE) -- Mythic Therapeutics, a biotechnology company focused on the development of antibody-drug conjugate-based
0 Comments